
Eli Lilly’s Experimental Pill Could Help You Ditch GLP-1 Obesity Shots, Trial Finds
Published on December 18, 2025
People who switched from semaglutide or tirzepatide to orforglipron largely maintained their weight loss.

People who switched from semaglutide or tirzepatide to orforglipron largely maintained their weight loss.